Antitumor antibiotic. Has higher cytotoxicity toward cultured human leukemia (HL-60) cells than actinomycin D (Prod. No. ALX-380-009). Induces cell death via apoptosis.
Product Specification
| Identity: | Determined by 1H-NMR: Identical to standard reference. |
| |
| Formula: | C62H84N12O17 |
| |
| MW: | 1269.4 |
| |
| Purity: | ≥95% (solvent free) |
| |
| Appearance: | Orange crystals. |
| |
| CAS: | 18865-48-0 |
| |
| Source/Host: | Isolated from Streptomyces sp. |
| |
| Solubility: | Soluble in methanol, acetone or chloroform. |
| |
| Long Term Storage: | +4°C |
| |
| Hazard: | TOXIC. |
| |
| Handling: | Keep cool and dry. |
| |
Please mouse over
Product Literature References
Characterization of Streptomyces MITKK-103, a newly isolated actinomycin X2-producer: K. Kurosawa, et al.; Appl. Microbiol. Biotechnol.
72, 145 (2006),
Abstract;
Correlation of actinomycin X2 to the lipid profile in static and shaken cultures of Streptomyces nasri strain YG62: M.Y. el-Naggar, et al.; Microbios.
100, 117 (1999),
Abstract;
Nomenclature of the Actinomycins: S.A. Waksman, et al.; PNAS
44, 602 (1958),
Abstract;